Novavax Inc vs Toyota Motor Corp — how do they compare? Novavax Inc trades at $8.08 (market cap $1.30B), while Toyota Motor Corp trades at $180.4 (market cap $212.22B). The key difference: Toyota Motor Corp is far larger — about 163.2× Novavax Inc's market cap, and Toyota Motor Corp pays a 3.51% dividend while Novavax Inc pays none. Which is the better fit depends on your goals.
| NVAX | TM | |
|---|---|---|
Market Cap | $1.30B | $212.22B |
Sector | Health | Consumer Cyclical |
52-Week High | $11.19 | $248.29 |
52-Week Low | $6.22 | $166.50 |
Enterprise Value | $800.50M | $376.42B |
Dividend Yield | — | 3.51% |
Signals from Pluang's Aura AI — not financial advice
Novavax (NVAX) trades at $8.08, down 1.64% on the day, with a bearish technical signal but strong recent earnings beats. The company reported $1.12B revenue in 2025 with a net income of $440.30M, though 2026 projections show a return to losses. Analyst consensus is bullish with a $14.00 price target, but negative shareholder equity and cash flow concerns persist.
Outlook remains mixed: strong valuation ratios and analyst support suggest upside potential, but negative cash flows, high liabilities, and projected 2026 losses pose significant risks. Investor sentiment is cautious amid recent stock declines and shareholder dissent highlighted in recent news.
No Aura AI signal available yet.
Trailing returns across standard periods
Latest headlines on both assets
Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.
Read more on NVAX →Founded in 1937, Toyota is one of the world's largest automakers with 10.38 million units sold at retail in fiscal 2022 across its light vehicle brands. Brands include Toyota, Lexus, Daihatsu, and truck maker Hino.
Read more on TM →